# AKYNZEO
> **NDA205718** · New Drug Application · Sponsor: HELSINN HLTHCARE · Approved 2014-10-10
## Drug
- **FDA Application Number:** NDA205718
- **Application type:** New Drug Application
- **Brand name:** AKYNZEO
- **Generic name:** NETUPITANT AND PALONOSETRON
- **Active ingredients:** NETUPITANT; PALONOSETRON HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HELSINN HLTHCARE
- **Manufacturer:** Helsinn Therapeutics (U.S.), Inc.
- **First approval:** 2014-10-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205718)
---
*AI Analytics · CC0 1.0*